Global Small Molecule API Market 2020-2027 by Source (Synthetic, Semi-synthetic, Natural), Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Region: Trend Forecast and Growth Opportunity

Publish Date : 2021-06-13 | Publisher : Grace Market Research | No Of Page : 165 | Report Id : MRB000132043 |

   

Report

MRB

Global Small Molecule API Market 2020-2027 by Source (Synthetic, Semi-synthetic, Natural), Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Region: Trend Forecast and Growth Opportunity

Publish Date: 2021-06-13 No Of Page: 165 Report Id: MRB000132043 Publisher: Grace Market Research Category: Others

Global small molecule active pharmaceutical ingredient (API) market will reach $266.2 billion by 2027, growing by 7.3% annually over 2020-2027 owing to increasing incidences of diseases, development of companies engaged in the manufacturing of small molecule APIs, the increasing technological developments in manufacturing sector, and surge in healthcare expenditure amid COVID-19 pandemic. Highlighted with 85 tables and 85 figures, this 165-page report “Global Small Molecule API Market 2020-2027 by Source (Synthetic, Semi-synthetic, Natural), Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global small molecule API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global small molecule API market in every aspect of the classification from perspectives of Source, Type, Therapeutic Area, Application, Manufacturer Type, and Region. Based on Source, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section. • Synthetic API o Branded Synthetic API o Generic Synthetic API • Semi-synthetic API • Natural Origin Based on Type, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section. • Standard API • High Potency API (HPAPI) o Branded HPAPI o Generic HPAPI Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section. • Infectious Diseases • Oncology • Ophthalmology • Cardiovascular Disorders • Central Nervous System • Respiratory Disorders • Metabolic Diseases • Other Applications Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section. o Clinical Use o Commercial Use Based on Manufacturer Type, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section. • Pharmaceutical Companies (also breakdown by region) • CMOs (also breakdown by region) Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE, Saudi Arabia, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Type, Therapeutic Area, and Manufacturer Type over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): Aurobindo Pharma Ltd. Cambrex Corporation Catalent, Inc. Dr. Reddy's Laboratories Ltd. GlaxoSmithKline plc Lonza Group Merck & Co., Inc. Mylan N.V. Novartis AG Pfizer Inc. Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. Wuxi AppTec Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 8 1.1 Industry Definition and Research Scope 8 1.1.1 Industry Definition 8 1.1.2 Research Scope 9 1.2 Research Methodology 12 1.2.1 Overview of Market Research Methodology 12 1.2.2 Market Assumption 13 1.2.3 Secondary Data 13 1.2.4 Primary Data 13 1.2.5 Data Filtration and Model Design 15 1.2.6 Market Size/Share Estimation 16 1.2.7 Research Limitations 17 1.3 Executive Summary 18 2 Market Overview and Dynamics 21 2.1 Market Size and Forecast 21 2.1.1 Impact of COVID-19 on World Economy 22 2.1.2 Impact of COVID-19 on the Market 24 2.2 Major Growth Drivers 26 2.3 Market Restraints and Challenges 29 2.4 Emerging Opportunities and Market Trends 32 2.5 Porter’s Fiver Forces Analysis 36 3 Segmentation of Global Market by Source 40 3.1 Market Overview by Source 40 3.2 Synthetic API 42 3.2.1 Branded Synthetic API 43 3.2.2 Generic Synthetic API 44 3.3 Semi-synthetic API 45 3.4 Natural Origin 46 4 Segmentation of Global Market by Type 47 4.1 Market Overview by Type 47 4.2 Standard API 49 4.3 High Potency API (HPAPI) 50 4.3.1 Branded HPAPI 51 4.3.2 Generic HPAPI 52 5 Segmentation of Global Market by Therapeutic Area 53 5.1 Market Overview by Therapeutic Area 53 5.2 Infectious Diseases 55 5.3 Oncology 56 5.4 Ophthalmology 57 5.5 Cardiovascular Disorders 58 5.6 Central Nervous System 59 5.7 Respiratory Disorders 60 5.8 Metabolic Diseases 61 5.9 Other Applications 62 6 Segmentation of Global Market by Application 63 6.1 Market Overview by Application 63 6.2 Clinical Use 65 6.3 Commercial Use 66 7 Segmentation of Global Market by Manufacturer Type 67 7.1 Market Overview by Manufacturer Type 67 7.2 Pharmaceutical Companies 69 7.3 CMOs 71 8 Segmentation of Global Market by Region 73 8.1 Geographic Market Overview 2020-2027 73 8.2 North America Market 2020-2027 by Country 77 8.2.1 Overview of North America Market 77 8.2.2 U.S. 80 8.2.3 Canada 84 8.2.4 Mexico 86 8.3 European Market 2020-2027 by Country 88 8.3.1 Overview of European Market 88 8.3.2 UK 91 8.3.3 France 93 8.3.4 Germany 95 8.3.5 Spain 97 8.3.6 Italy 99 8.3.7 Russia 101 8.3.8 Rest of European Market 103 8.4 Asia-Pacific Market 2020-2027 by Country 105 8.4.1 Overview of Asia-Pacific Market 105 8.4.2 China 108 8.4.3 Japan 110 8.4.4 India 113 8.4.5 Australia 115 8.4.6 South Korea 117 8.4.7 Rest of APAC Region 119 8.5 South America Market 2020-2027 by Country 121 8.5.1 Argentina 124 8.5.2 Brazil 126 8.5.3 Chile 128 8.5.4 Rest of South America Market 130 8.6 MEA Market 2020-2027 by Country 131 8.6.1 UAE 134 8.6.2 Saudi Arabia 136 8.6.3 South Africa 138 8.6.4 Other National Markets 140 9 Competitive Landscape 141 9.1 Overview of Key Vendors 141 9.2 New Product Launch, Partnership, Investment, and M&A 144 9.3 Company Profiles 145 Aurobindo Pharma Ltd. 145 Cambrex Corporation 147 Catalent, Inc. 148 Dr. Reddy's Laboratories Ltd. 149 GlaxoSmithKline plc 150 Lonza Group 151 Merck & Co., Inc. 152 Mylan N.V. 153 Novartis AG 154 Pfizer Inc. 155 Sun Pharmaceutical Industries Ltd. 156 Teva Pharmaceutical Industries Ltd. 157 Wuxi AppTec Co., Ltd. 158 10 Investing in Global Market: Risk Assessment and Management 159 10.1 Risk Evaluation of Global Market 159 10.2 Critical Success Factors (CSFs) 162 Related Reports and Products 165

Table 1. Snapshot of Global Small Molecule API Market in Balanced Perspective, 2020-2027 19 Table 2. Growth Rate of World GDP, 2020-2022 23 Table 3. Main Product Trends and Market Opportunities in Global Small Molecule API Market 32 Table 4. Global Small Molecule API Market by Source, 2017-2027, $ mn 40 Table 5. Global Small Molecule API Market: Synthetic API by Drug Type, 2017-2027, $ mn 42 Table 6. Global Small Molecule API Market by Type, 2017-2027, $ mn 47 Table 7. Global Small Molecule API Market: HPAPI by Drug Type, 2017-2027, $ mn 50 Table 8. Global Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 53 Table 9. Global Small Molecule API Market by Application, 2017-2027, $ mn 63 Table 10. Global Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 67 Table 11. Global Small Molecule API Market by Region, 2017-2027, $ mn 74 Table 12. Leading National Small Molecule API Market, 2020 and 2027, $ mn 76 Table 13. North America Small Molecule API Market by Country, 2017-2027, $ mn 79 Table 14. U.S. Small Molecule API Market by Type, 2017-2027, $ mn 82 Table 15. U.S. Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 82 Table 16. U.S. Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 82 Table 17. Canada Small Molecule API Market by Type, 2017-2027, $ mn 85 Table 18. Canada Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 85 Table 19. Canada Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 85 Table 20. Mexico Small Molecule API Market by Type, 2017-2027, $ mn 87 Table 21. Mexico Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 87 Table 22. Mexico Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 87 Table 23. Europe Small Molecule API Market by Country, 2017-2027, $ mn 90 Table 24. UK Small Molecule API Market by Type, 2017-2027, $ mn 92 Table 25. UK Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 92 Table 26. UK Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 92 Table 27. France Small Molecule API Market by Type, 2017-2027, $ mn 94 Table 28. France Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 94 Table 29. France Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 94 Table 30. Germany Small Molecule API Market by Type, 2017-2027, $ mn 96 Table 31. Germany Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 96 Table 32. Germany Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 96 Table 33. Spain Small Molecule API Market by Type, 2017-2027, $ mn 98 Table 34. Spain Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 98 Table 35. Spain Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 98 Table 36. Italy Small Molecule API Market by Type, 2017-2027, $ mn 100 Table 37. Italy Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 100 Table 38. Italy Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 100 Table 39. Russia Small Molecule API Market by Type, 2017-2027, $ mn 102 Table 40. Russia Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 102 Table 41. Russia Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 102 Table 42. Small Molecule API Market in Rest of Europe by Country, 2017-2027, $ mn 104 Table 43. APAC Small Molecule API Market by Country, 2017-2027, $ mn 107 Table 44. China Small Molecule API Market by Type, 2017-2027, $ mn 109 Table 45. China Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 109 Table 46. China Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 109 Table 47. Japan Small Molecule API Market by Type, 2017-2027, $ mn 112 Table 48. Japan Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 112 Table 49. Japan Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 112 Table 50. India Small Molecule API Market by Type, 2017-2027, $ mn 114 Table 51. India Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 114 Table 52. India Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 114 Table 53. Australia Small Molecule API Market by Type, 2017-2027, $ mn 116 Table 54. Australia Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 116 Table 55. Australia Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 116 Table 56. South Korea Small Molecule API Market by Type, 2017-2027, $ mn 118 Table 57. South Korea Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 118 Table 58. South Korea Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 118 Table 59. Small Molecule API Market in Rest of APAC by Country/Region, 2017-2027, $ mn 120 Table 60. South America Small Molecule API Market by Country, 2017-2027, $ mn 123 Table 61. Argentina Small Molecule API Market by Type, 2017-2027, $ mn 125 Table 62. Argentina Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 125 Table 63. Argentina Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 125 Table 64. Brazil Small Molecule API Market by Type, 2017-2027, $ mn 127 Table 65. Brazil Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 127 Table 66. Brazil Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 127 Table 67. Chile Small Molecule API Market by Type, 2017-2027, $ mn 129 Table 68. Chile Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 129 Table 69. Chile Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 129 Table 70. MEA Small Molecule API Market by Country, 2017-2027, $ mn 133 Table 71. UAE Small Molecule API Market by Type, 2017-2027, $ mn 135 Table 72. UAE Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 135 Table 73. UAE Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 135 Table 74. Saudi Arabia Small Molecule API Market by Type, 2017-2027, $ mn 137 Table 75. Saudi Arabia Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 137 Table 76. Saudi Arabia Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 137 Table 77. South Africa Small Molecule API Market by Type, 2017-2027, $ mn 139 Table 78. South Africa Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn 139 Table 79. South Africa Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn 139 Table 80. Aurobindo Pharma Ltd.: Company Snapshot 145 Table 81. Aurobindo Pharma Ltd.: Business Segmentation 145 Table 82. Aurobindo Pharma Ltd.: Product Portfolio 146 Table 83. Aurobindo Pharma Ltd.: Revenue, 2017-2019, $ mn 146 Table 84. Risk Evaluation for Investing in Global Market, 2020-2027 160 Table 85. Critical Success Factors and Key Takeaways 163

Global Automotive Cybersecurity Market 2021-2030 by Solution, Product Type, Product Form, Threat Type, Application, Automotive Component, Vehicle Type, and Region: Trend Forecast and Growth Opportunity

Global automotive cybersecurity market will reach $10.92 billion by 2030, growing by 21.7% annually over 2020-2030 owing to the rising need for cybersecurity among smart vehicles, self-driving cars and connected transportatio ...
Published Date :  2021-06-13

Global Low Speed Electric Vehicle (LSEV) Market 2020-2030 by Product (Two-wheelers, Three-wheelers, Four-wheelers), Voltage, Battery, Vehicle Type, End User, and Region: Trend Forecast and Growth Opportunity

Global low speed electric vehicle market will reach $22.35 billion by 2030, growing by 12.3% annually over 2020-2030 owing to stringent environmental regulations, improvement in electric vehicle R&D, advanced battery technolo ...
Published Date :  2021-06-13

Global Autonomous Vehicle Vision and Navigation System Market 2020-2030 by Offering, Vehicle Type, Level of Autonomy (L1 - L5), Distribution Channel, and Region: Trend Forecast and Growth Opportunity

Global autonomous vehicle vision and navigation system market will reach $130.91 billion by 2030, growing by 22.5% annually over 2020-2030 owing to technological advancements in deep learning for image processing and governme ...
Published Date :  2021-06-13

Global Wireless Electric Vehicle Charging Market 2020-2030 by Charging Technology, Power Source, Component, Charging Type, Propulsion Type, Vehicle Type, Application, Distribution Channel, and Region: Trend Forecast and Growth Opportunity

Global wireless electric vehicle charging market will reach $333.0 million by 2030, growing by 41.3% annually over 2020-2030 owing to surging sales of electric vehicles due to growing awareness about vehicle emissions and gov ...
Published Date :  2021-06-13

Global Organic Coffee Market 2020-2030 by Origin (Arabica, Robusta), Coffee Type (Fair Trade, Gourmet, Espresso, Coffee Pods), Roast (Light, Medium, Dark), Packaging Type, End User, Distribution Channel, and Region: Trend Forecast and Growth Opportunity

Global organic coffee market will reach $20.78 billion by 2030, growing by 10.6% annually over 2020-2030 owing to the increase in consumption of healthy and organic products, and increasing demand for organic coffee for confe ...
Published Date :  2021-06-13